Home / Investors / Financial Information / Five-Year Financial Summary

Five-Year Financial Summary

In millions, except per share amounts 2017 2016 2015 2014 2013
Statement of operations data:
Net revenues $ 184,765 $ 177,526 $ 153,290 $ 139,367 $ 126,761
Gross profit 28,545 28,857 26,528 25,367 23,783
Operating expenses(1) 19,028 18,519 17,074 16,568 15,746
Operating profit 9,517 10,338 9,454 8,799 8,037
Interest expense, net 1,041 1,058 838 600 509
Loss on early extinguishment of debt 643 521
Other expense 208 28 21 23 33
Income tax provision 1,637 3,317 3,386 3,033 2,928
Income from continuing operations 6,631 5,320 5,230 4,645 4,600
Income (loss) from discontinued operations, net of tax (8) (1) 9 (1) (8)
Net income 6,623 5,319 5,239 4,644 4,592
Net loss attributable to noncontrolling interest (1) (2) (2)
Net income attributable to CVS Health $ 6,622 $ 5,317 $ 5,237 $ 4,644 $ 4,592
Per common share data:
Basic earnings per common share:
Income from continuing operations attributable to CVS Health $ 6.48 $ 4.93 $ 4.65 $ 3.98 $ 3.78
Loss from discontinued operations attributable to CVS Health $ (0.01) $ 0.00 $ 0.01 $ 0.00 $ (0.01)
Net income attributable to CVS Health $ 6.47 $ 4.93 $ 4.66 $ 3.98 $ 3.77
Diluted earnings per common share:
Income from continuing operations attributable to CVS Health $ 6.45 $ 4.91 $ 4.62 $ 3.96 $ 3.75
Loss from discontinued operations attributable to CVS Health $ (0.01) $ 0.00 $ 0.01 $ 0.00 $ (0.01)
Net income attributable to CVS Health $ 6.44 $ 4.90 $ 4.63 $ 3.96 $ 3.74
Cash dividends per common share $ 2.00 $ 1.70 $ 1.40 $ 1.10 $ 0.90
Balance sheet and other data:
Total assets $ 95,131 $ 94,462 $ 92,437 $ 73,202 $ 70,550
Long-term debt $ 22,181 $ 25,615 $ 26,267 $ 11,630 $ 12,767
Total shareholders’ equity $ 37,695 $ 36,834 $ 37,203 $ 37,963 $ 37,938
Number of stores (at end of year) 9,846 9,750 9,681 7,866 7,702

(1) As of January 1, 2017, the Company adopted Accounting Standards Update (“ASU”) 2017-07, Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which resulted in a retrospective reclassification of $28 million, $21 million, $23 million and $33 million of net benefit costs from operating expenses to other expense in the years ended December 31, 2016, 2015, 2014, and 2013, respectively.